NasdaqGS:PRVAHealthcare
A Look At Privia Health Group (PRVA) Valuation As EHR Cancer Screening Program Beats National Benchmarks
Privia Health Group (PRVA) is in focus after releasing a case study with Amalgam Rx and Exact Sciences on an EHR-integrated colorectal cancer screening program that surpassed national CRC screening benchmarks during Colorectal Cancer Awareness Month.
See our latest analysis for Privia Health Group.
Despite the positive attention around the EHR-integrated screening program, Privia Health Group’s recent share price performance has been softer, with a 7.8% 90 day share price return decline and a...